Atorbir atorvastatin tablets

Atorbir is a prescription generic medication containing the active ingredient atorvastatin, widely prescribed to lower low-density lipoprotein (LDL) cholesterol and manage cardiovascular risk. The product is marketed in Sweden by Bluefish Pharmaceuticals AB, an established generic pharmaceutical company headquartered in Stockholm.

Bluefish Pharmaceuticals was founded in Sweden in 2005 with the goal of providing cost-effective generic prescription medications across European markets. The company develops and markets generic pharmaceuticals with finished dose manufacturing typically contracted to qualified European pharmaceutical production sites, including facilities in Portugal.

Bluefish Pharmaceuticals AB is privately held, with its primary shareholder base rooted in Sweden, led by company co-founder and major investor Karl Karlsson alongside institutional and private Nordic investors.